:: Library Catalog

Cover Image

Saved in:

Bibliographic Details
Main Authors:	Anand R. Shewale, Weijie Poh, Michael L. Reed, Jinjie Liu, Francois Cadiou, Ali Ezzati, Kate Burslem, Shivaji Manthena, Richard B. Lipton
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	Headache: The Journal of Head and Face Pain
Online Access:	https://headachejournal.onlinelibrary.wiley.com/doi/10.1111/head.14839
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Comparative analysis of real‐world acute prescription migraine therapy outcomes: Insights from the HeAD – US study
by: Devin Teichrow, et al.
Published: (2026)

Real‐world barriers to health care utilization among people living with migraine: Insights from the All of Us Research Program
by: Idris Demirsoy, et al.
Published: (2025)

Milk and plasma pharmacokinetics of single‐dose ubrogepant in healthy lactating women
by: Ramesh R. Boinpally, et al.
Published: (2025)

Characterizing gaps in the preventive pharmacologic treatment of migraine: Multi‐country results from the CaMEO‐I study
by: Dawn C. Buse, et al.
Published: (2024)

Challenges and opportunities for estimating and assessing migraine prevalence, incidence and impact across study populations and methodologies: Bridging global and United States findings
by: Fred Cohen, et al.
Published: (2024)

Prevalence and burden of migraine in the United States: A systematic review
by: Fred Cohen, et al.
Published: (2024)

What a long strange trip it's been: Reflections on serial snapshots of migraine prevalence and burden in the United States
by: Fred Cohen, et al.
Published: (2025)

A 52‐week open‐label extension study to evaluate the safety and efficacy of oral rimegepant for the preventive treatment of migraine
by: David Kudrow, et al.
Published: (2025)

Patient reported outcomes and the real‐world use of calcitonin gene–related peptide medications in migraine
by: Samuel K. Peasah, et al.
Published: (2024)

Unmet treatment needs in migraine: Results of the OVERCOME (US) study
by: Susan Hutchinson, et al.
Published: (2026)

Development of the Migraine‐Related Stigma (MiRS) Questionnaire: Results of the OVERCOME (US) Study
by: Elizabeth K. Seng, et al.
Published: (2025)

A randomized, open‐label, 5‐period crossover study evaluating the pharmacokinetics and safety of a single dose of intranasal dihydroergotamine (DHE) powder (STS101), intramuscular DHE mesylate, and liquid nasal spray DHE in healthy adults
by: Richard B. Lipton, et al.
Published: (2024)

Sustained benefits of onabotulinumtoxinA treatment in chronic migraine: An analysis of the pooled Phase 3 REsearch Evaluating Migraine Prophylaxis Therapy (PREEMPT) randomized controlled trials
by: Stephen D. Silberstein, et al.
Published: (2024)

Patient preferences for the preventive treatment of episodic migraine in the United States: A discrete‐choice experiment
by: Richard B. Lipton, et al.
Published: (2025)

Integrating gepants into clinical practice for the acute treatment of migraine
by: Richard B. Lipton, et al.
Published: (2026)

Rates and healthcare resource utilization for people with branded acute and preventive migraine prescription medication order payer denials: An open, multi‐source dataset, observational cohort study
by: Dawn C. Buse, et al.
Published: (2026)

Treatment effectiveness of galcanezumab versus traditional oral migraine preventive medications at 3 months: Results from the TRIUMPH study
by: Richard B. Lipton, et al.
Published: (2025)

Characterizing the patient experience during the prodrome phase of migraine: A qualitative study of symptoms and their timing
by: Richard B. Lipton, et al.
Published: (2025)

Reasons for patient reluctance to take preventive medications for migraine: Results of the OVERCOME ( US ) study
by: Jessica Ailani, et al.
Published: (2026)

Rates and risk factors for migraine progression using multiple definitions of progression: Results of the longitudinal OVERCOME ( US ) study
by: Dawn C. Buse, et al.
Published: (2025)

The impacts of migraine on functioning: Results from two qualitative studies of people living with migraine
by: Rikki Mangrum, et al.
Published: (2024)

Routine migraine screening as a standard of care for Women's health: A position statement from the American Headache Society
by: Todd J. Schwedt, et al.
Published: (2025)

Navigating the patient journey in migraine prevention: An American Migraine Foundation position paper
by: Lawrence C. Newman, et al.
Published: (2025)

Incidence and outcome of sudden severe headache in the emergency department
by: Ane Skaare Sjulstad, et al.
Published: (2025)

Depression and anxiety are not associated with migraine outcomes in children and adolescents
by: Amy A. Gelfand
Published: (2024)

Characteristics of men and women with medically diagnosed cluster headache in a national integrated healthcare system: A Veterans Health Administration cohort study
by: Elizabeth K. Seng, et al.
Published: (2024)

Anxiety and depressive symptoms and migraine‐related outcomes in children and adolescents
by: Bilal Ahmed Rizvi, et al.
Published: (2024)

Do patients with migraine and obesity receive different treatments? Insights from real‐world data
by: Keshet Pardo, et al.
Published: (2025)

Preliminary prospective observational investigation of clinical outcomes among treatment‐seeking youth with continuous headache
by: Robert C. Gibler, et al.
Published: (2024)

Sex differences in the clinical manifestations and treatment outcomes in a large cohort of spontaneous intracranial hypotension
by: Po‐Tso Lin, et al.
Published: (2024)

Epidemiology and characteristics of status migrainosus in a tertiary headache clinic: A retrospective cohort study
by: Evelyn Dorsey, et al.
Published: (2026)

Challenges in the management of new daily persistent headache at a tertiary headache center—A retrospective real‐world evidence study
by: Thor Linnet, et al.
Published: (2024)

Combination behavioral and pharmacological interventions through telehealth platforms: Opportunities for increasing access and optimizing migraine outcomes
by: Teshamae S. Monteith, et al.
Published: (2025)

Assessing blood pressure changes and hypertension‐related outcomes in patients with migraine treated with erenumab: A systematic review and meta‐analysis
by: Luana Miyahira Makita, et al.
Published: (2025)

Deep brain stimulation for chronic refractory cluster headache: A case series about long‐term outcomes and connectivity analysis
by: Juan Ángel Aibar‐Durán, et al.
Published: (2024)

Building a national headache medicine research network: The BE WELL with Migraine Champion Providers Network™
by: Rebecca Erwin Wells, et al.
Published: (2025)

Effect of erenumab versus other migraine preventive medications on cardiovascular and cerebrovascular outcomes: A United States claims database‐based observational cohort study
by: David W. Dodick, et al.
Published: (2025)

The pathogenic role of calcitonin gene‐related peptide and predictors of new‐onset migraine and long‐term outcomes after transcatheter atrial septal defect closure
by: Tzu‐Hsuan Su, et al.
Published: (2024)

Quality of life changes in cluster headache: Convergent validity, responsiveness, and interpretability of the Cluster Headache Quality of Life scale as a patient‐reported outcome measure
by: Willemijn C. Naber, et al.
Published: (2025)

A 3‐year follow‐up study of outcomes associated with patterns of traditional acute and preventive migraine treatment: An administrative claims‐based cohort study in the United States
by: Shivang Joshi, et al.
Published: (2024)